Cover Image
Market Research Report

Indonesia Pharmaceuticals & Healthcare Q2 2019

Published by Fitch Solutions, Inc. Product code 177846
Published Content info 88 Pages
Delivery time: 1-2 business days
Back to Top
Indonesia Pharmaceuticals & Healthcare Q2 2019
Published: March 12, 2019 Content info: 88 Pages

Key View:

We forecast the Indonesian pharmaceutical market to be among the fastest growing in the ASEAN region. Government incentives to boost domestic medicine production will provide drugmakers long-term investment opportunities. We also note that revenue growth potential is significant due to Indonesia's expansion of healthcare access as the national health insurance scheme rolls out. However, growth will be driven primarily by generic drug sales given the country's limited purchasing power.

Table of Contents
Product Code: SSID03_20190401

Table of Contents

Key View


Industry Forecast

  • Pharmaceutical Market Forecast
  • Healthcare Market Forecast
  • Prescription Drug Market Forecast
  • Patented Drug Market Forecast
  • Generic Drug Market Forecast
  • OTC Medicine Market Forecast
  • Pharmaceutical Trade Forecast

Industry Risk/Reward Index

  • Asia Pacific Innovative Pharmaceuticals Risk/Reward Index
  • Indonesia Innovative Pharmaceuticals Risk/Reward Index

Regulatory Development

  • Regulatory Review

Market Overview

Competitive Landscape

Company Profile

  • Bayer
  • Darya-Varia Group
  • GlaxoSmithKline
  • Indofarma
  • Kimia Farma
  • Merck & Co
  • Merck Group
  • Novartis
  • Pfizer
Back to Top